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Materials and methods
The Global Burden of Disease Study in Brazil was conducted by the Center for Research in Applied Methods for Global Burden of Disease Studies at the Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation (ENSP/Fiocruz) in 2010-2013, using 2008 as the reference year for the data analysis. The study was approved by the Institutional Review Board of ENSP/Fiocruz (CAAE: 0054.0.031.000-11).
The indicator used in burden of disease studies is disability-adjusted life year (DALY), a summary measure aimed at grasping the impact of morbidity and mortality on the population's state of health. DALY thus consists of two components, one that measures years of life lost to premature death (years of life lost -YLLs) and another that measures years of healthy life lost due to health problems or disability (years lived with disability -YLDs) 13 . Meanwhile, health problems/chronic complications are subdivided into major analytical groups: I -communicable diseases, maternal/perinatal conditions, and nutritional conditions; II -non-communicable diseases; and III -external causes.
To calculate DALYs, a 3% discount on future benefits was adopted. YLLs were estimated considering deaths from a given disease and life expectancy in Japan according to the reference methodology proposed by Murray & Lopez 13 . Mortality data were obtained from the Mortality Information System (SIM) of the SUS, taking the mean value for [2007] [2008] [2009] . Deaths were then selected whose principal cause was coded from E10 to E14 in the International Classification of Diseases, 10 th revision (ICD-10), disaggregated by state, gender, and age bracket. A correction was performed for under-recording of deaths in each state of Brazil, according to gender and age bracket, with a national correction of 28% for individuals under 1 year of age and 13% for individuals over 1 year. According to the traditional Global Burden of Disease Study methodology, deaths from ill-defined causes and cases defined as garbage codes were redistributed proportionally by gender, age bracket, and cause of death in each state of Brazil 14 .
YLDs were calculated with incident cases, duration of disease, and weight of disabilities taken from the Global Burden of Disease Study in 1990 13 . YLDs were calculated for uncomplicated cases of type 2 diabetes mellitus and the chronic complications considered in Global Burden of Disease Stud: diabetic retinopathy (DR), blindness due to DR (B-DR), diabetic neuropathy (DN), diabetic chronic renal failure (CRF-D), diabetic foot (DF), and amputations. The definitions used in the study were those proposed by Lopez et al. 15 .
After a literature review for definition of clinical and epidemiological parameters on diabetes and related chronic complications, a consensus seminar was held with experts in type 2 diabetes mellitus and its complications, including endocrinologists, ophthalmologists, and clinicians, selected to cover the range of clientele (public and private) and practices in outpatient and hospital care administration, teaching, and research. This selection procedure aimed to avoid biases in selection and measurement of parameters defined by consensus. The expert panel was intended to agree on parameters to be included subsequently in modeling in the DisMod II package (EpiGear, Noosa, Australia; http://www. epigear.com/index_files/dismod_ii.html) 16 19 was used to estimate prevalence of B-DR. Incidence of CRF-D was estimated using data from the Outpatient Information System of the SUS (SIA-SUS), compiling the Authorizations for High-Complexity Procedures (APAC) for the year 2008, in which 25.7% of cases with ICD-10 codes N18 or N19 and 41.8% of cases with type 2 diabetes mellitus and arterial hypertension were attributed to type 2 diabetes mellitus 20 . Incidence of amputations was estimated using data from the Hospital Admissions System of the SUS (SIH-SUS) by compiling Authorizations for Hospital Admissions (AIH). The mean for years 2008 to 2010 was used, and 50% of total non-traumatic amputations were attributed to type 2 diabetes mellitus 21 . This incidence was later corrected, taking as the target the percentage of the population with private health plans in relation to the percentage without such plans, according to data from the Brazilian National Health Agency 22 (correction factor: 1.27 Brazil; 1.10 North and Northeast; 1.50 Southeast; 1.26 South; and 1.16 Central-West). Incidence of diabetic foot was estimated based on the incidence of amputation 23 .
The study assumed remission zero for uncomplicated cases of type 2 diabetes mellitus, DR, B-DR, DN, and amputation and 9.5% remission for CRF-D, considering transplant cases registered in 2008 in APAC. The study used relative risk (RR) of mortality from type 2 diabetes mellitus of 2.0 between 30 and 69 years and 1.0 under 29 years and 70 years and older. For DR, B-DR, and DN, we used RR of 1.0 in the age bracket up to 29 years and 2.0 for 30 years and older (parameters agreed on in the expert consensus). RR for amputation was generated by the ratio between mean RR of uncomplicated diabetes mellitus cases 24 and the RRs reported by Begg et al. 23 . Case-fatality from CRF-D was calculated using the number of deaths recorded in 2008 in APAC.
DisMod II 16 was used to estimate parameters not available in the literature and to test the internal consistency of the available parameters. After modeling, for individuals up to 29 years of age, the value zero was assigned to incidence rates of uncomplicated cases of type 2 diabetes mellitus and chronic complications. Entry variables in the data modeling were prevalence (type 2 diabetes mellitus, DR, B-DR, and DN) or incidence (CRF-D and amputation) of diseases, remission, mortality (only for t6ype 2 diabetes mellitus), case-fatality (only for CRF-D), and RR (type 2 diabetes mellitus, DR, B-DR, DN, and amputation). Modeling was not necessary for DF, since the incidence was used, estimated from amputations (ratio 1:10) and duration of 2 months for the condition 23 .
For uncomplicated cases of type 2 diabetes mellitus, B-DR, DN, DF, amputation, and CRF-D, we used the weights for disabilities reported by Murray & Lopez 13 . For type 2 diabetes mellitus, B-DR, Cad . Saúde Pública 2017; 33(2):e00197915 DN, and DF, the weights were weighted by the proportion of treatment for each condition (50%, 0%, 40%, 40%, and 0%, respectively), agreed on in the expert consensus. DR used the mean weight reported by Stouthard et al. 25 weighted by the prevalence of types of DR. Table 1 describes the methodology used to obtain the clinical-epidemiological parameters. Data analysis used the SPSS, version 17.0 (SPSS Inc., Chicago, USA), and estimates were calculated for Brazil and its major geographic regions, stratified by gender and age. Table 1 shows the incidence rates per 100 thousand inhabitants for type 2 diabetes mellitus cases and chronic complications in men and women in Brazil, after modeling in DisMod II. In general, no relevant differences were found between incidence rates in men and women, with slightly higher rates in men and for amputation and diabetic foot. Chronic complications with the highest incidence were DN and diabetic foot. Table 2 shows YLLs, YLDs, and DALYs for all non-communicable diseases and injuries (Group II) and specifically for type 2 diabetes mellitus in Brazil and by region. There were 195 DALYs per 1,000 inhabitants in Brazil in 2008. Group II of CNCDs accounted for approximately 77% of the burden of disease that year, ranging from 71.5% in the North to 79.5% in the Southeast. Group II also showed a high share of YLLs and YLDs (65.3% and 89%, respectively).
Results
Type 2 diabetes mellitus accounted for nearly 5% of the burden of disease in Brazil, with 9.2 DALYs per 1,000 inhabitants. Among non-communicable diseases (Group II), the share of type 2 diabetes mellitus was higher: 6.1% in Brazil as a whole (Table 2) .
Table 1
Parameters used to estimate number of disability-adjusted life years (DALYs) due to type 2 diabetes mellitus and chronic complications. Brazil, 2008. The largest component of the type 2 diabetes mellitus burden was morbidity (53.2%), with 930,478 YLDs. The type 2 diabetes mellitus share of total YLDs for Group II was higher in the South and Southeast, with 7.1% and 6%, respectively, when compared to the national mean of 5.6%. The share of type 2 diabetes mellitus in total YLLs for Brazil was 4.5% (816,716 YLLs), reaching 5.4% in the Northeast. Specifically within Group II, the share of diabetes mellitus increased to 6.9%, with even higher regional rates in the Northeast and North (8.3% and 7%, respectively) ( Table 2 ). Figure 1 shows the ranking of DALYs from type 2 diabetes mellitus compared to other health problems by age bracket and gender. In all groups starting at 30 years and in both genders, type 2 diabetes mellitus ranked among the five leading health problems in terms of burden of disease in Brazil. Type 2 diabetes mellitus ranked 2 nd in men 59 years or younger, dropping to 5 th starting at 60 years. Among women, type 2 diabetes mellitus ranked 2 nd and 3 rd in the 30-44 and 45-69-year age brackets, respectively, dropping to 4 th in women 70 years or older.
Parameters
There was a higher proportion of DALYs from type 2 diabetes mellitus in individuals 30 to 59 years of age (59.7%). As for gender, men up to 59 years of age had a slightly higher share of DALYs when compared to women. From 60 years onward there was a higher share in women in the 60-69 and 70 and older age brackets (55.5% and 63.2%, respectively). As for the distribution of YLDs and YLLs in the composition of DALYs from type 2 diabetes mellitus according to age bracket, up to 59 years of age there was a higher proportion of DALYs attributed to morbidity, especially in the 30 to 44-year age bracket, with 86.8% YLDs. From 60 years on there was a reversal of this profile, with a larger share of the mortality component, especially in the 70 and older age bracket, with 82.1% YLLs. That is, age showed an important gradient in the increasing share of mortality from type 2 diabetes mellitus ( Figure 2) .
As for type 2 diabetes mellitus and its various chronic complications, the burden of morbidity (YLDs) consisted mainly of diabetic retinopathy (42.4%), DN (27.7%) and uncomplicated cases of type 2 diabetes mellitus (20.9%). Regional variation in YLDs showed a concentration in the Southeast. The proportion of YLDs according to regions for type 2 diabetes mellitus as a whole (cases and chronic complications) was 47.3% in the Southeast and 6.1% in the North (Table 3) . 
Discussion
This study addressed the importance of CNCDs and type 2 diabetes mellitus in Brazil's epidemiological scenario. According to the main findings, type 2 diabetes mellitus showed the most important share among CNCDs, ranking 2 nd in DALYs. The share of YLLs increased with age, especially in Northeast Brazil, while YLDs consisted mostly of chronic complications and were concentrated in the most developed and urbanized regions of Brazil.
The estimated total number of DALYs dropped by approximately 1.5% compared to the GBD Study for Brazil in 1998, consistent with the results of the recent world Global Burden of Disease Study of 2010 1 . The results were also similar for the share of type 2 diabetes mellitus in total DALYs, which remained around 5% in the last 10 years in Brazil. However, the share of type 2 diabetes mellitus in total DALYs from Group II increased when compared to the share in the Global Burden of Disease Study for Brazil in 1998, from 66.3% to 77.2%.
The share of YLDs in total DALYs from type 2 diabetes mellitus remained higher in the last 10 years when compared to the share of YLLs, which can be explained by the increase in prevalence and maintenance of the mortality rate from type 2 diabetes mellitus in Brazil 6, 26 . According to Newton et al. 27 , who analyzed burden of disease in England, there was an important reduction in the burden of mortality due to diabetes, from 1990 (17 th place), to 2005 (27 th place), to 2013 (not ranking among the first 31 places).
Cad. Saúde Pública 2017; 33(2):e00197915 Northeast Brazil was the only region in which the type 2 diabetes mellitus profile showed a higher proportion of YLLs than YLDs in DALYs. This may reflect a lower rate of early diagnosis due to difficulties in access to health services as well as barriers to on-going treatment, thereby increasing the share of mortality in type 2 diabetes mellitus. Other relevant aspects include health education issues both with diabetics and health professionals and treatment adherence in a chronic condition like type 2 diabetes mellitus.
Brazil's hinterlands and less economically developed regions have experienced difficulties in implementing the SUS ever since its creation. Since most of these small and/or remote communities have small populations, they suffer from inadequate human and financial resources and infrastructure 28 . Mendes et al. 29 presented the results of a study in a state capital in Northeast Brazil which revealed great dissatisfac-Cad. Saúde Pública 2017; 33(2):e00197915 tion with the SUS among users and health professionals, due to difficulties with the supply of medicines, tests, and specialized referrals, besides the long waiting time in primary care units.
Type 2 diabetes mellitus in the current study was among the 10 leading causes of DALYs (3 rd in women and 6 th in men), similar to the 8 th place for tropical Latin America estimated in the world Global Burden of Disease Study 1 . This illustrates the relevance of type 2 diabetes mellitus in Brazil, especially due to the rising prevalence of risk factors like obesity and sedentary lifestyle 5, 18, 30 . The estimated burden was higher in young populations, reaching 2 nd place in the 30-44-year age group, when compared to the elderly, in whom the burden of cardiac diseases and dementias lead the ranking. The share of YLLs was also higher in DALYs from type 2 diabetes mellitus in the elderly due to this age group's higher mortality rate 10 .
Uncomplicated cases represented only 20.9% of YLDs from type 2 diabetes mellitus, reflecting Brazil's currently challenging situation with early detection and treatment of cases (which should aim to prevent chronic complications). According to Guidoni et al. 31 , the Family Health Strategy, currently the main primary care mechanism in the SUS, fails to fully meet with the prevention and health promotion recommendations for type 2 diabetes mellitus, thus generating gaps that are ultimately reflected in heavy expenditures on high-complexity expenditures for diabetics. Evaluating the profile of type 2 diabetes mellitus patients hospitalized in the SUS, Artilheiro et al. 32 showed that the majority reported treatment for systemic arterial hypertension or some comorbidity associated with type 2 diabetes mellitus, such as DN, DR, or peripheral vascular disease. In addition, 24% of these patients had failed to consult a primary care unit in the previous 12 months due to lack of open slots for scheduling appointments, and that 54% had failed to consult an endocrinologist in the previous 3 years due to lack of referral.
Examples of the impact of chronic complications of type 2 diabetes mellitus on patients' health are DR and B-DR, jointly accounting for approximately 45% of all YLDs due to type 2 diabetes mellitus, 9 times the percentage when compared to estimates from the world Global Burden of Disease Study. DR is considered the principal cause of blindness in individuals 20 to 74 years of age, and an estimated 38% of individuals with type 2 diabetes mellitus present some degree of DR at diagnosis 10 .
According to Rezende et al. 33 , some 30% of annual cases of DF in Brazil required hospitalization and some 48% of the costs of these admissions related to amputations. There has been a large increase in major amputations, which the same authors attributed to failure in treatment of DF. The situation is even more complicated because diabetic neuropathy is the main cause of ulcers, often detected at first diagnosis of type 2 diabetes mellitus 10 .
Concerning diabetic chronic renal failure, according to Cherchiglia et al. 34 , 20% of patients that began dialysis in the SUS in 2000 presented diabetes as the cause of CRF. Patients were followed for a mean of 4 years, and annual expenditure per patient ranged from approximately BRL 27,000 to BRL 35,000 (USD 8,000-USD 11,000)
Regardless of the type of chronic complication, the greatest obstacles to decreasing their share of total YLDs in type 2 diabetes mellitus relate to effective early diagnosis and efficient treatment of the disease, both of which are still highly precarious in primary care in Brazil. Importantly, since type 2 diabetes mellitus is a difficult disease to manage, prognosis depends largely on lifestyle changes in combination with access to medication, as well as treatment compliance. According to Alfradique et al. 35 , type 2 diabetes mellitus is a primary care-sensitive health condition, that is, the hospitalization rates can be decreased by effective measures in primary care. Relatively simple preventive and curative measures can be developed to diagnose and follow individuals with diabetes and consequently avoid chronic complications or delay their progression 10, 30, 32, 36, 37 .
This study shares two limitations with all studies on global burden of disease in the world: (i) the scarcity of nationally representative studies that estimate diabetes mellitus prevalence and incidence rates and chronic complications, as well as the duration and proportion of treatments performed and (ii) underreporting and incorrect classification of deaths. Another inherent limitation to the traditional method of Global Burden of Disease Studies is the exhaustive list of complications to be investigated, evidencing the absence of acute complications from the list, notably hypoglycemia and hyperglycemia, since complications are frequent in patients with diabetic nephropathy and result in emergency department visits or even hospitalizations.
The last multicenter study in Brazil on type 2 diabetes mellitus prevalence in the population using diagnostic tests was in 1986-1988. The current study adjusted this estimate according to the prevalence Cad. Saúde Pública 2017; 33(2):e00197915 of overweight and obese individuals in the Brazilian population, resulting in a 9.7% rate in adults 30 years or older (10.3% in men and 9.1% in women). Considering the difficulties in correctly classifying the share of deaths from acute myocardial infarction attributed to type 2 diabetes mellitus, in the current study the burden of deaths from acute myocardial infarction was computed in the group of ischemic heart diseases rather than as a type 2 diabetes mellitus-associated comorbidity.
The findings corroborate studies on the relevance of type 2 diabetes mellitus in Brazil and worldwide in recent decades. The YLD rate per 1,000 inhabitants is more than half the rate of the entire group that includes infectious and parasitic diseases, maternal causes, perinatal causes, and nutritional deficiencies. The findings thus have implications for planning actions in the Brazilian health system. Since diabetes is a primary care-sensitive condition, it is hoped that strengthening primary care by including relatively simple preventive and curative measures will positively impact the diagnosis and follow-up of individuals with diabetes, thus preventing diabetes mellitus and chronic complications or delaying the latter's progression, helping to enhance care and quality of life for these patients. 
